PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
As the pandemic continues and COVID-19 cases rise across our nation, it can be challenging to sort through all the news. Promising scientific advances in…
On November 20, 2020, the Trump administration finalized rules aimed at reducing the costs of drugs. Michael Kolodij, PharmD, unpacks both: “Most Favored Nation” rule…
New opportunity to proactively manage the total cost of diabetes care with integrated data on the powerful Artemetrx technology platform PLANO, Texas–(BUSINESS WIRE)–Pharmaceutical Strategies…
Diabetes is a top category of spend for most plan sponsors. According to the American Diabetes Association, people diagnosed with diabetes incur average medical expenditures…
Join the discussion already in progress as we shift gears from last week’s installment on “Unpacking utilization and medical pharmacy integration” to this week’s…
Another double-digit increase (13.6%) in per member per year cost underscores the need for close monitoring and management of specialty. Successfully partnering with health plans…
Thinking back to one year ago, when writing this commentary on the upcoming 2020 formulary changes, no one could have foreseen the challenges and difficulties…
Actionable insights for specialty drug cost savings delivered in PSG’s fourth annual integrated pharmacy and medical benefit report PLANO, Texas–(BUSINESS WIRE)–Pharmaceutical Strategies Group (PSG) unveils…
Understanding the importance of delivering “an effective formulary strategy” to achieve cost containment in these challenging times, CVS has revealed their 2021 formulary changes. While…
Looking toward 2021, OptumRx has announced its formulary changes effective January 1, 2021. These changes will include a combination of downtiers, uptiers, and exclusions with…
